COVID-19: epidemiological update. Weekly report. Week 51. 30 December 2021.
Key points
In week 51, the circulation of SARS-CoV-2 surged with strong growth in Omicron, which is now the dominant variant.
Metropolitan France:
Incidence rate* above 1,000/100,000 inhabitants in Île-de-France, Provence-Alpes-Côte d’Azur, Corsica, and Auvergne-Rhône-Alpes
Largest increase in the incidence rate* among 20-29 and 30-39 year-olds
New hospital and intensive care admissions stable but high at the national level with regional disparities
Overseas France:
Sharp rise in the incidence rate* in Guadeloupe and Mayotte
Incidence rate still very high in Reunion Island
Variants
62.4% of screened tests showing a profile compatible with the Omicron variant at the start of week 52
Omicron representing 15% of interpretable sequences in the Flash Survey from week 50 (13 December)
Prevention
Vaccination on 28 December 2021 (Vaccin Covid data):
77,0% of the French population had received a complete primary vaccination series
43.7% of the 18+ age group (80.7% of eligible people) and 70.6% of the 65+ age group (87.9% of eligible people) had received a booster shot
Importance of combining different measures: complete vaccination schedule (including complete primary vaccination and booster shot after 3 months) as well as adherence to contact tracing and recommended guidelines
Compliance with preventive measures, including reducing contacts and frequently ventilating enclosed spaces, is essential during the end-of-year festive period given the circulation of the Omicron variant
En relation avec
Nos dernières actualités
actualité
Lancement du réseau « chaleur-santé-bâti-urbanisme » : vers des villes et...
actualité
Enquête « Rapport au sexe » (ERAS) 2026 à destination des hommes ayant des...
actualité